Skip to main content

Part of the book series: Contemporary Endocrinology ((COE,volume 21))

  • 93 Accesses

Abstract

Biologic assays employed for screening novel peptides, once sequenced, or even during initial purification attempts, have evolved over the years from whole-animal models to isolated tissue systems in perfusion chambers, and, most recently, to systems employing cultured mammalian cells. The end product of these most recent bioassay systems can be monitored on the basis of cell growth or division, hormone secretion, or even changes in intracellular signaling events. It was using just such a bioassay that Matsuo et al. (1), in 1993, isolated a novel vasoactive hormone, termed adrenomedullin (AM). The peptide stimulated platelet adenylyl cyclase activity, and then, in whole-animal bioassay, was found to be a potent vasodilator (1). This chapter describes the identification of the pharmacologic and physiologic properties of AM and its sibling pair, proadrenomedullin N-terminal 20 peptide (PAMP), with particular focus on production in, and the effects on, the cardiovascular system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553–560.

    Article  PubMed  CAS  Google Scholar 

  2. Kitamura K, Sakata J, Kangawa K, Kojima H, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993; 194: 720–725.

    Article  PubMed  CAS  Google Scholar 

  3. Ishimitsu T, Kojima M, Hino J, Matsuoka H, Kitamura K, Eto T, Matsuo H. Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 1994; 203: 631–639.

    Article  PubMed  CAS  Google Scholar 

  4. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun 1993; 195: 921–927.

    Article  PubMed  CAS  Google Scholar 

  5. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994; 338: 6–10.

    Article  PubMed  CAS  Google Scholar 

  6. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, Sasano H, Mouri T. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and adrenal gland. Neurosci Lett 1996; 203: 207–210.

    Article  PubMed  CAS  Google Scholar 

  7. Washimine H, Asada Y, Kitamura K, Ichiki Y, Hara S, Yamamoto Y, et al Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissue. Histochem Cell Biol 1995; 103: 251–254.

    Article  PubMed  CAS  Google Scholar 

  8. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett 1994; 352: 105–108.

    Article  PubMed  CAS  Google Scholar 

  9. Ueta Y, Kitamura K, Isse T, Shibuya I, Kabashima N, Yamamoto S, et al. Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci Lett 1995; 202: 37–40.

    Article  PubMed  CAS  Google Scholar 

  10. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160–1166.

    Article  PubMed  CAS  Google Scholar 

  11. Nishimori T, Tsujino M, Sato K, Imai T, Marumo F, Hirata Y. Dexamethasone-induced up-regulation of adrenomedullin and atrial natriuretic peptide genes in cultured rat ventricular myocytes. J Mol Cell Cardiol 1997; 29: 2125–2130.

    Article  PubMed  CAS  Google Scholar 

  12. Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, et al. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension 1998; 31: 505–510.

    Article  PubMed  CAS  Google Scholar 

  13. Chun TH, Itoh H, Ogawa Y, Tamura N, Takaya K, Igaki T, et al. Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension 1997; 29: 1296–1302.

    Article  PubMed  CAS  Google Scholar 

  14. Jougasaki M, Wei CM, Mckinley II, Burnett JC. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1995; 92: 286–289.

    Article  PubMed  CAS  Google Scholar 

  15. Minamino N, Shoji H, Sugo S, Kangawa K, Matsuo H. Adrenocortical steroids, thyroid hormones and retinoic acid augment the production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 211: 686–693.

    Article  PubMed  CAS  Google Scholar 

  16. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, et al. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J Clin Endocrinol Metab 1995; 80: 1750–1752.

    Article  PubMed  CAS  Google Scholar 

  17. Katoh F, Kitamura K, Niina H, Yamamoto R, Washimine H, Kangawa K, et al. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J Neurochem 1995; 64: 459–461.

    Article  PubMed  CAS  Google Scholar 

  18. Romppanen H, Marttila M, Magga J, Vuolteenaho O, Kinnunen P, Szokodi I, Ruskaoho H. Adrenomedullin gene expression in the rat heart is stimulated by acute pressure overload: blunted effect in experimental hypertension. Endocrinology 1997; 138: 2636–2639.

    Article  PubMed  CAS  Google Scholar 

  19. Samson WK. Cardiovascular hormones. In: Conn PM, Melmed S, eds. Endocrinology, Basic and Clinical Principles, Humana, Totowa, 1997, pp. 361–376.

    Google Scholar 

  20. Shimokubo T, Sakata J, Kitamura K, Kangawa K, Matsuo H, Eto T. Augmented adrenomedullin concentrations in right ventricle and plasma of experimental pulmonary hypertension. Life Sci 1995; 57: 1771–1779.

    Article  PubMed  CAS  Google Scholar 

  21. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 207: 25–32.

    Article  PubMed  CAS  Google Scholar 

  22. Kitamura K, Ichiki Y, Tanaka M, Kawamoto M, Emura J, Sakakibara S, et al. Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994; 341: 288–290.

    Article  PubMed  CAS  Google Scholar 

  23. Sato K, Hirata Y, Imai T, Iwashina M, Marumo F. Characterization of immunoreactive adrenomedullin in human plasma and urine. Life Sci 1995; 57: 189–194.

    Article  PubMed  CAS  Google Scholar 

  24. Washimine H, Yamamoto Y, Kitamura K, Tanaka M, Ichiki Y, Kangawa K, Matsuo H, Eto T. Plasma concentrations of human adrenomedullin in patients on hemodialysis. Clin Nephrol 1995; 44: 389–393.

    PubMed  CAS  Google Scholar 

  25. Meeran K, O’Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH, Bloom SR. Circulating adrenomedullin does not regulate systemic BP but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 1997; 82: 95–100.

    Article  PubMed  CAS  Google Scholar 

  26. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994; 94: 2158–2161.

    Article  PubMed  CAS  Google Scholar 

  27. Kohno M, Hanehira T, Kano H, Horio T, Yokokawa K, Ikeda M, et al. Plasma adrenomedullin concentrations in essential hypertension. Hypertension 1996; 27: 102–107.

    Article  PubMed  CAS  Google Scholar 

  28. Cheung B, Leung R. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin Sci 1997; 92: 59–62.

    PubMed  CAS  Google Scholar 

  29. Taniyama M, Kitamura K, Ban Y, Sigita E, Ito K, Katagiri T. Elevation of circulating proadrenomedullin N-20 terminal peptide in thyrotoxicosis. Clin Endocrinol 1997; 46: 271–274.

    Article  CAS  Google Scholar 

  30. Kohno M, Hanehira T, Hirata K, Kawaguchi T, Okishio K, Kano H, Kanazawa H, Yoshikawa J. Accelerated increase of plasma adrenomedullin in acute asthma. Metabolism 1996; 45: 1323–1325.

    Article  PubMed  CAS  Google Scholar 

  31. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 1996; 81: 1449–1453.

    Article  PubMed  CAS  Google Scholar 

  32. Nishio K, Akai Y, Murao Y, Doi N, Ueda S, Tabuse H, et al. Increased plasma concentration of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 1997; 25: 953–957.

    Article  PubMed  CAS  Google Scholar 

  33. Shoji H, Minamino N, Kangawa K, Matsuo H. Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem Biophys Res Commun 1995; 215: 531–537.

    Article  PubMed  CAS  Google Scholar 

  34. Sugo S, Minamino N, Shoji H, Kangawa K, Matsuo H. Effects of vasoactive substance and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells. FEBS Lett 1995; 369: 311–314.

    Article  PubMed  CAS  Google Scholar 

  35. Kuchinke W, Hart RP, Jonakait GM. Identification of mRNAs regulated by interferon-gamma in cultured rat astrocytes by PCR differential display. Neuroimmunomodulation 1995; 2: 347–355.

    Article  PubMed  CAS  Google Scholar 

  36. Elhawary AM, Poon J, Pang CC. Effects of calcitonin gene related peptide antagonists on renal actions of adrenomedullin. Br J Pharmacol 1995; 115: 1133–1140.

    Article  PubMed  CAS  Google Scholar 

  37. Baskaya M, Suzuki Y, Anzai M, Seki Y, Saito K, Takayasu M, Shibuya M, Sigita K. Effects of adrenomedullin, calcitonin gene related peptide, and amylin on cerebral circulation in dogs. J Cereb Blood Flow Metab 1995; 15: 827–834.

    Article  PubMed  CAS  Google Scholar 

  38. Mori T, Takayasu M, Suzuki Y, Shibuya M, Yoshida J, Hidaka H. Effects of adrenomedullin on rat cerebral arterioles. Eur J Pharmacol 1997; 330: 195–198.

    Article  PubMed  CAS  Google Scholar 

  39. Berthiaume N, Claing A, Lippton H, Cadieux A, D’Orleans-Juste P. Rat adrenomedullin induces selective arterial vasodilation via CGRP1 receptors in the double perfused mesenteric bed of the rat. Can J Physiol Pharmacol 1995; 73: 1080–1083.

    Article  PubMed  CAS  Google Scholar 

  40. Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K, Eto T, Wada A. Vasodilator effect of adrenomedullin and calcitonin gene related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 1993; 96: 245–251.

    Article  Google Scholar 

  41. Lang MG, Paterno R, Faraci FM, Heistad DD. Mechanisms of adrenomedullin induced dilatation of cerebral arterioles. Stroke 1997; 28: 181–185.

    Article  PubMed  CAS  Google Scholar 

  42. Gardiner SM, Kemp PA, March JE, Bennett T. Regional hemodynamic effects of human and rat adrenomedullin in conscious rats. Br J Pharmacol 1995; 114: 584–591.

    Article  PubMed  CAS  Google Scholar 

  43. Haynes JM, Cooper ME. Adrenomedullin and calcitonin gene related peptide in the rat isolated kidney and the anesthetized rat: in vitro and in vivo effects. Eur J Pharmacol 1995; 280: 91–94.

    Article  PubMed  CAS  Google Scholar 

  44. Hjelmqvist H, Keil R, Mathai M, Hubschle T, Gertsberger R. Vasodilation and glomerular binding of adrenomedullin in rabbit kidney are not CGRP receptor mediated. Am J Physiol 1997; 273: R716 - R724.

    PubMed  CAS  Google Scholar 

  45. Aiyar, H, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y. cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 1996;271:11, 325–11, 329.

    Google Scholar 

  46. Owji AA, Smith DM, Coppock HA, Morgan DGA, Bhogal R, Ghatei MA, Bloom SR. Abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 1995; 136: 2127–2134.

    Article  PubMed  CAS  Google Scholar 

  47. Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, Kitamura K, Eto T, Matsuo H. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation, and calcium mobilization, in bovine aortic endothelial cells. J Biol Chem 1995; 270: 4412–4417.

    Article  PubMed  CAS  Google Scholar 

  48. Samson WK, Murphy TC, Schell DA. Novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology 1995; 136: 2349–2352.

    Article  PubMed  CAS  Google Scholar 

  49. Sabates BL, Pigott JD, Choe EU, Cruz MP, Lippton HL, Hyman AL, Flint LM, Ferrara JJ. Adrenomedullin mediates coronary vasodilation through adenosine receptors and KATP channels. J Surg Res 1997; 67: 163–168.

    Article  PubMed  CAS  Google Scholar 

  50. Iwasaki H, Hirata Y, Iwashina M, Sato K, Marumo F. Specific binding for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat. Endocrinology 1996; 137: 3045–3050.

    Article  PubMed  CAS  Google Scholar 

  51. Feng CJ, Kang B, Kaye AD, Kadowitz PJ, Nossman BD. L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat. Life Sci 1994; 55: 433–438.

    Google Scholar 

  52. Shimosawa T, Ito Y, Ando K, Kitamura K, Kangawa K, Fujita T. Proadrenomedullin NH2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J Clin Invest 1995; 96: 1672–1676.

    Article  PubMed  CAS  Google Scholar 

  53. Takano K, Yamashita N, Fujita T. Proadrenomedullin N-terminal 20 peptide inhibits the voltage-gated calcium channel current through a pertussis toxin-sensitive G protein in rat pheochromocytomaderived PC12 cells. J Clin Invest 1996; 98: 14–17.

    Article  PubMed  CAS  Google Scholar 

  54. Lainchbury JG, Cooper GJ, Coy DH, Jiang NY, Lewis LK, Yandle TG, Richards AM, Nicholls MG. Adrenomedullin: a hypotensive hormone in man. Clin Sci 1997; 92: 467–472.

    PubMed  CAS  Google Scholar 

  55. Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation 1997; 95: 1214–1221.

    Article  PubMed  CAS  Google Scholar 

  56. Fukuhara M, Tsuchihashi T, Abe I, Fujishima M. Cardiovascular and neurohumoral effects of intravenous adrenomedullin in conscious rabbits. Am J Physiol 1995; 269: R1289 - R1293.

    PubMed  CAS  Google Scholar 

  57. Kohno M, Yasunari Y, Yokokawa K, Horio T, Ikeda M, Minami M, Hanehira T, Yoshikawa J. Interaction of adrenomedullin and platelet derived growth factor on the production of endothelin. Hypertension 1996; 27: 663–667.

    Article  PubMed  CAS  Google Scholar 

  58. Nakamura K, Toda H, Terasako K, Nakuyama M, Hatano Y, Mori K, Kangawa K. Vasodilative effect of adrenomedullin in isolated arteries of the dog. Jpn J Pharmacol 1995; 67: 259–262.

    Article  PubMed  CAS  Google Scholar 

  59. Kato J, Kitamura K, Kangawa K, Eto T. Receptors for adrenomedullin in human vascular endothelial cells. Eur J Pharmacol 1995; 289: 383–385.

    Article  PubMed  CAS  Google Scholar 

  60. Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe TX, et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994; 340: 226–230.

    Article  PubMed  CAS  Google Scholar 

  61. Kureshi Y, Kobayashi S, Nishimura J, Nakano T, Kanaide H. Adrenomedullin decreases both cytosolic calcium concentration and calcium sensitivity in pig coronary arterial smooth muscle. Biochem Biophys Res Commun 1995; 212: 572–579.

    Article  Google Scholar 

  62. Kano H, Kohno M, Yasunari K, Yokokawa K, Horio T, Ikeda M, et al. Adrenomedullin as a novel antiproliferative factor in vascular smooth muscle cells. J Hypertension 1996; 14: 209–213.

    Article  CAS  Google Scholar 

  63. Kohno M, Yokokawa K, Kano H, Yasunari K, Minami M, Hanehira T, Yoshikawa J. Adrenomedullin is a potent inhibitor of angiotensin II induced migration of human coronary artery smooth muscle cells. Hypertension 1997; 29: 1309–1313.

    Article  PubMed  CAS  Google Scholar 

  64. Chini EN, Choi E, Grande JP, Burnett JC, Douse TP. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem Biophys Res Commun 1995; 215: 868–873.

    Article  PubMed  CAS  Google Scholar 

  65. Kato H, Shichiri M, Marumo F, Hirata Y. Adrenomedullin as an autocrine/paracrine survival factor for rat endothelial cells. Endocrinology 1997; 138: 2615–2620.

    Article  PubMed  CAS  Google Scholar 

  66. Ebara T, Mura K, Okumura M, Matsuura T, Kim S, Yukimura T, Iwao H. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur J Pharmacol 1994; 263: 69–73.

    Article  PubMed  CAS  Google Scholar 

  67. Jougasaki M, Wei CM, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am J Physiol 1995; 268: F657 - F663.

    PubMed  CAS  Google Scholar 

  68. Hirata Y, Hayakawa H, Suzuki Y, Suzuki Y, Ikenouchi H, Kohmoto O, et al. Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension 1995; 25: 790–795.

    Article  PubMed  CAS  Google Scholar 

  69. Owada A, Nonoguchi H, Terada Y, Marumo F, Tomita K. Microlocalization and effects of adrenomedullin in nephron segments and in mesangial cells of the rat. Am J Physiol 1997; 272: F691 - F697.

    PubMed  CAS  Google Scholar 

  70. Yokoi H, Arima T, Kondo K, Iwasaki Y, Oiso Y. Intracerebroventricular injection of adrenomedullin inhibits vasopressin release in conscious rats. Neurosci Lett 1996; 216: 65–67.

    Article  PubMed  CAS  Google Scholar 

  71. Andreis PG, Neri G, Prayer-Galetti T, Rossi GP, Gottardo G, Malendowicz LK, Nussdorfer GG. Effects of adrenomedullin on the human adrenal glands: an in vitro study. J Clin Endocrinol Metab 1997; 82: 1167–1170.

    Article  PubMed  CAS  Google Scholar 

  72. Yamaguchi T, Baba K, Doi Y, Yano K. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci 1995; 56: 379–387.

    Article  PubMed  CAS  Google Scholar 

  73. Jougasaki M, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC. Role of prostaglandins and renal nerves in the renal actions of adrenomedullin. Am J Physiol 1997; 272: F260 - F266.

    PubMed  CAS  Google Scholar 

  74. Segawa K, Minami K, Sata T, Kuroiwa A, Shigematsu A. Inhibitory effect of adrenomedullin on rat mesangial cell mitogenesis. Nephron 1996; 74: 577–579.

    Article  PubMed  CAS  Google Scholar 

  75. Edwards RM, Trizna W, Stack E, Aiyar N. Effect of adrenomedullin on cAMP levels along the rat nephron: comparison with CGRP Am J Physiol 1996; 271: F895 - F899.

    CAS  Google Scholar 

  76. Jensen BL, Kramer BK, Kurtz A. Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells. Hypertension 1997; 29: 1148–1155.

    Article  PubMed  CAS  Google Scholar 

  77. Andreis PG, Mazzocchi G, Rebuffat P, Nussdorfer GG. Effects of adrenomedullin and proadrenomedullin N-terminal 20 peptide on rat zona glomerulosa cells. Life Sci 1997; 60: 1693–1697.

    Article  PubMed  CAS  Google Scholar 

  78. Parkes DG, May CN. 1995; ACTH-suppressive and vasodilator actions of AM in conscious sheep. J Neuroendocrinology 7: 923–929.

    Article  CAS  Google Scholar 

  79. Grantham JA, Burnett JC. Natriuretic peptides in cardiovascular disease. In: Samson WK, Levin ER, eds. Contemporary Endocrinology, Natriuretic Peptides in Health and Disease Humana, Totowa, 1997, pp. 309–326.

    Google Scholar 

  80. Sumimoto T, Nishikimi T, Mukai M, Matsuzaki K, Murakami E, Takishita S, Miyata A, Matsuo H, Kangawa K. Plasma adrenomedullin concetrations and cardiac and arterial hypertrophy in hypertension. Hypertension 1997; 30: 741–745.

    Article  PubMed  CAS  Google Scholar 

  81. Inatsu H, Sakata J, Shimokubo T, Kitani M, Nishizoni M, Washimine H, et al. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat. Biochem Mol Biol Int 1996; 38: 365–372.

    PubMed  CAS  Google Scholar 

  82. Sato A, Autelitano DJ. Adrenomedullin induces expression of c-fos and AP-1 activity in rat vascular smooth muscle cells and cardiomyocytes. Biochem Biophys Res Commun 1995; 217: 211–216.

    Article  PubMed  CAS  Google Scholar 

  83. Sato A, Canny BJ, Autelitano DJ. Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocyte. Biochem Biophys Res Commun 1997; 230: 311–314.

    Article  PubMed  CAS  Google Scholar 

  84. Szokodi I„ Kinnunen P„ Ruskoaho H. Inotropic effect of AM in the isolated perfused rat heart. Acta Physiol Scand 1996; 156: 151–152.

    Article  PubMed  CAS  Google Scholar 

  85. Parkes DG. Cardiovascular actions of adrenomedullin in conscious sheep. Am J Physiol 1995; 268: H2574 - H2578.

    PubMed  CAS  Google Scholar 

  86. Charles CJ, Rademaker MT, Richards AM, Cooper CJ, Coy DH, Jing NY, Nicholls MG. Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep. Am J Physiol 1997; 272: R2040 - R2047.

    PubMed  CAS  Google Scholar 

  87. Parkes DG, May CN. Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol 1997; 120: 1179–1185.

    Article  PubMed  CAS  Google Scholar 

  88. Rademaker MT, Charles CJ, Lewis LK, Yandle TG, Cooper GJ, Coy DH, Richards AM, Nicholls MG. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 1997; 96: 1983–1990.

    Article  PubMed  CAS  Google Scholar 

  89. DeWitt BJ, Cheng DY, Caminiti GN, Nossaman BD, Coy DH, Murphy WA, Kadowitz PA. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in pulmonary vascular bed of the cat. Eur J Pharmacol 1994; 257: 303–306.

    Article  PubMed  CAS  Google Scholar 

  90. Shirai M, Shimouchi A, Ikeda S, Ninomiya I, Sunagawa K, Kangawa K, Matsuo H. Vasodilator effects of adrenomedullin on small pulmonary arteries and veins in anesthetized cats. Br J Pharmacol 1997; 121: 679–686.

    Article  PubMed  CAS  Google Scholar 

  91. Yang BC, Lippton H, Gumusel B, Hyman A, Mehta JL. Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins, J Cardiovasc Pharmacol 1997; 28: 458–462.

    Article  Google Scholar 

  92. Yoshibayashi M, Kamiya T, Kitamura K, Saito Y, Kangawa K, Nishikimi T, et al. Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients *20 years of age. Am J Cardiol 1997; 79: 1558–1558.

    Article  Google Scholar 

  93. deVroomen M, Takahashi Y, Gournay V, Roman C, Rudolph AM, Heyman MA. Adrenomedullin increases pulmonary blood flow in fetal sheep. Pediatr Res 1997; 41: 493–497.

    Article  CAS  Google Scholar 

  94. Kamoi H, Kanazawa K, Hirata K, Kurihara N, Yano Y, Otani S. Adrenomedullin inhibits the secretion of cytokine induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem Biophys Res Commun 1995; 211: 1031–1035.

    Article  PubMed  CAS  Google Scholar 

  95. Allen MA, Ferguson AV. In vitro recordings from area postrema neurons demonstrate responsiveness to adrenomedullin. Am J Physiol 1996; 270: R920 - R925.

    PubMed  CAS  Google Scholar 

  96. Yeung VT, Ho SK, Nicholls MG, Cockram CS. Adrenomedullin, a novel vasoactive hormone, binds to mouse astrocytes and stimulates cyclic AMP production. J Neurosci Res 1996; 46: 330–335.

    Article  PubMed  CAS  Google Scholar 

  97. Dogan A, Suzuki Y, Koketsu N, Osuka K, Saito K, Takayasu M, Shibuya M, Yoshida J. Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1997; 17: 19–25.

    Article  PubMed  CAS  Google Scholar 

  98. Zimmerman U, Fischer JA, Frei K, Fischer AH, Reinscheid RK, Muff R. Identification of adrenomedullin receptors in cultured rat astrocytes and in neuroblastoma x glioma hybrid cells (NG 108–15). Brain Res 1996; 724: 238–245.

    Article  CAS  Google Scholar 

  99. Levin ER. Natriuretic peptide C-receptor: more than a clearance receptor. Am J Physiol 1993; 264: E484 - E489.

    Google Scholar 

  100. Murphy TC, Samson WK. Novel vasoactive hormone, adrenomedullin, inhibits water drinking in the rat. Endocrinology 1995; 136: 2459–2463.

    Article  PubMed  CAS  Google Scholar 

  101. Samson WK, Murphy TC. Adrenomedullin inhibits salt appetite. Endocrinology 1996; 138: 613–616.

    Article  Google Scholar 

  102. Krahn DD, Gosnell BA, Levine AS, Morley JE. Effects of calcitonin gene related peptide on food intake. Peptides 1984; 5: 861–864.

    Article  PubMed  CAS  Google Scholar 

  103. Taylor GM, Meeran K, O’Shea D, Smith DM, Ghatei MA, Bloom SR. Adrenomedullin inhibits feeding in the rat by a mechanism involving calcitonin gene related peptide receptors. Endocrinology 1996; 137: 3260–3264.

    Article  PubMed  CAS  Google Scholar 

  104. Samson WK, Murphy TC, Resch ZT. Central mechanisms for the hypertensive effects of preproAM derived peptides in conscious rats. Am J Physiol 1998; 274: R1505 — R1510.

    PubMed  CAS  Google Scholar 

  105. Blackburn RE, Samson WK, Fulton RJ, Stricker EM, Verbalis JG. Central oxytocin inhibition of salt appetite in rats: evidence for differential sensing of plasma sodium and osmolality. Proc Natl Acad Sci USA 1993;90:10, 380–10, 384.

    Google Scholar 

  106. Blackburn RE, Samson WK, Fulton RJ, Stricker EM, Verbalis JG. Central oxytocin and ANP receptors mediate osmotic inhibition of salt appetite in rats. Am J Physiol 1995; 269: R245 - R251.

    PubMed  CAS  Google Scholar 

  107. Martinez V, Cuttitta F, Tache Y. Central action of adrenomedullin to inhibit gastric emptying in rats. Endocrinology 1997; 138: 3749–3755.

    Article  PubMed  CAS  Google Scholar 

  108. Takahashi H, Watanabe T, Nishimura M, Nakanishi T, Sakamoto M, Yoshimura M, et al. Centrally induced vasopressor and sympathetic responses to a novel endogenous peptide, adrenomedullin, in anesthetized rats. Am J Hypertension 1994; 7: 478–482.

    CAS  Google Scholar 

  109. Allen MA, Smith PA, Ferguson AV. Adrenomedullin microinjection into the area postrema increases blood pressure. Am J Physiol 1997; 272: R1698–1703.

    PubMed  CAS  Google Scholar 

  110. Samson WK, Murphy TC, Resch ZT. Proadrenomedullin N-20 terminal peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel. Endocrine 1998; 9: 269–272.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Samson, W.K. (1999). Adrenomedullin and the Heart. In: Share, L. (eds) Hormones and the Heart in Health and Disease. Contemporary Endocrinology, vol 21. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-708-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-708-6_2

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5420-9

  • Online ISBN: 978-1-59259-708-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics